SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
April 22, 2024 07:00 ET
|
SNIPR Biome
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients Phase 1b/2a trial will evaluate SNIPR001 for the...
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
April 22, 2024 02:00 ET
|
SNIPR Biome
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients Phase 1b/2a trial will evaluate SNIPR001 for the...
SNIPR Biome Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes
October 03, 2022 07:00 ET
|
SNIPR Biome
SNIPR Biome Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes Copenhagen, October 03, 2022: SNIPR Biome ApS (“SNIPR” or “the Company”), a company...
SNIPR Biome Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes
October 03, 2022 02:00 ET
|
SNIPR Biome
SNIPR Biome Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes Copenhagen, October 03, 2022: SNIPR Biome ApS (“SNIPR” or “the Company”), a company...
SNIPR Biome Granted New US Patent Covering Lytic CRISPR Phage
August 02, 2022 02:00 ET
|
SNIPR Biome
SNIPR Biome Granted New US Patent Covering Lytic CRISPR Phage Copenhagen, August 2nd, 2022: SNIPR Biome ApS (or “the Company”), a clinical-stage biotechnology company developing CRISPR-based...